Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. The notice about lapse in government funding was removed.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the publications section with a 2024 Blood article citation; the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:28:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Adds a glossary display option and updates QC metadata to Revision: v3.4.0, while removing older QC wording. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:22:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:46:35.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A publication citation in the Publications section (Friedberg et al., Blood 2024) was added and subsequently removed; this does not affect the study design, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-07T00:42:09.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing U.S. states and Canadian provinces. Updated the page to Revision: v3.3.3 and removed the older v3.3.2 location blocks and the HHS Vulnerability Disclosure content.
    Difference
    2%
    Check dated 2025-12-23T12:29:22.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.